[Screening of novel uric acid-lowering probiotics and evaluation of their probiotic properties].

D801 significantly attenuated hyperuricemia in mice, reducing the serum uric acid level by 20.65%. Moreover, the strain decreased the xanthine oxidase (XOD) activity by 36.24% and 13.54% in the mouse liver and serum, respectively. Importantly, it reduced the spleen index by 17.09%. The results suggest that strain D801 improves the immune function and alleviates systemic inflammation. The core significance of this study lies in offering a safer approach for hyperuricemia.